Literature DB >> 7977309

Ticlopidine and severe aplastic anemia.

J N Rodriguez, A Fernandez-Jurado, J C Dieguez, A Amian, D Prados.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7977309     DOI： 10.1002/ajh.2830470418

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

Review 2.  Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.

Authors:  S Noble; K L Goa
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 3.  Adverse haematological effects of ticlopidine. Prevention, recognition and management.

Authors:  B B Love; J Biller; M Gent
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

4.  A new model of busulphan-induced chronic bone marrow aplasia in the female BALB/c mouse.

Authors:  Frances M Gibson; C Michael Andrews; Paraskevi Diamanti; Sian Rizzo; George Macharia; Edward C Gordon-Smith; Thomas Williams; John Turton
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.